ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
DJ Europe Select Dividend 30 Index EUR

DJ Europe Select Dividend 30 Index EUR (DJEUDIV)

111.65
0.00
( 0.00% )
Updated: 20:00:00
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
111.65
Price Change
0.00
Change %
0.00%
Name
DJ Europe Select Dividend 30 Index EUR
Symbol
DJEUDIV
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Bid
0.00
Ask
0.00
Open
-
High
0.00
Low
0.00
Close
-
Previous Close
111.65
Market
Dow Jones Indices
Type
Index

DJEUDIV Latest News

PAOG 2021 CBD Nutraceuticals Sales Plan Preview This Friday To Include ALKM and USMJ Partnership Highlights

Sandusky, OH -- May 6, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today highlighted that the upcoming CBD Nutraceutical Sales Rollout Presentation scheduled for tomorrow...

PAOG 2021 CBD Nutraceuticals Rollout Preview This Friday To Include ALKM and USMJ Partnership Updates

Sandusky, OH -- May 5, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021. Last...

PAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This Friday

Sandusky, OH -- May 3, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced plans to present the company’s CBD Nutraceutical Sales Rollout Plan this Friday, May 7...

PAOG Announces Negotiations To Acquire Partnership Interest In Patented Cannabis Extraction Technology

Sandusky, OH -- April 13, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today released a management update on the company’s ongoing CBD Pharmaceutical Development Program...

PAOG Signals BUY - CBD Pharma Development Backed US Patent

April 12, 2021 -- InvestorsHub NewsWire -- via AmericanBulls.com/PAOG     PAO Group, Inc. (USOTC: PAOG) Our system’s recommendation today is to BUY...

PAOG U.S. Patent Backed CBD Pharmaceutical Development Remains On Track

Sandusky, OH -- April 8, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced a management update on the company’s ongoing CBD Pharmaceutical Development Program...

PAOG Targets September 2021 To Introduce CBD Nutraceuticals To Market Co-Packed By ALKM and Marketed Through USMJ

Sandusky, OH -- March 16, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today released details on the company’s nutraceutical developments initiative following last...

PAOG Announces Save The Date For CBD Nutraceuticals Expansion Update

Sandusky, OH -- March 10, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (OTC Pink: PAOG) today encouraged all interested to save the date, Tuesday, March 16, 2021, when PAOG will...

PAOG Announces RELAX-RX Nutraceutical For $18 Billion Anxiety And Depression Treatment Market

Sandusky, OH -- March 8, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced initiating the development of its new nutraceutical, RELAX-RX, targeting the anxiety and...

PAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation Subsidiary

Sandusky, OH -- February 3, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced the company anticipates reporting an estimated $50,000 in revenue for Q4 2020. The...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000IX
40000000IX
120000000IX
260000000IX
520000000IX
1560000000IX
2600000000IX
Indices
Commodities
Forex
US5005,306.10119.502.30%
US3039,452.00675.001.74%
US1002,550.5063.502.55%
DJI39,449.86686.411.77%
SP5005,321.44121.942.35%
COMPX16,664.43468.632.89%
DXY102.9030.6550.64%

Your Recent History

Delayed Upgrade Clock